首页> 外文期刊>Medicine. >Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease
【24h】

Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease

机译:免疫球蛋白G4相关硬化性疾病的胸腔内受累

获取原文
获取外文期刊封面目录资料

摘要

To investigate clinical and radiological features of IgG4-related disease (IgG4-RD) patients with intrathoracic involvement. A prospective cohort study was performed and IgG4-RD patients were enrolled from January 2011 to March 2015 in Peking Union Medical College Hospital, in which the clinical and radiological characteristics of IgG4-RD patients with intrathoracic involvement were summarized. Out of total 248 cases with IgG4-RD, 87 cases had intrathoracic lesions, including 58 male cases and 29 female cases, with average age of 54.19 ± 13.80 years. Hilar and mediastinal lymphadenopathy were the most common manifestations of IgG4-related intrathoracic disease, accounting for 52.9% (46/87). Other imaging findings of pulmonary disease included: solid nodular (25.3%), round-shaped ground-glass opacities (9.2%), alveolar-interstitial type (20.7%), bronchovascular type (23.0%), pleural effusion (4.6%), and pleural nodules or thickening (16.1%). Only 27 patients presented with respiratory symptoms, including cough, breathless, chest pain, and asthma. Compared with patients without intrathoracic disease, IgG4-related intrathoracic disease had higher IgG4 and C-reactive protein level, and higher incidence of allergy, fever, and multi-organ involvement. Most of lung interstitial disease, mediastinal mass, and bronchial thickening were sensitive to corticosteroid and immunosuppressant therapy, while 36.3% (8/22) of solitary nodular lesions were unresponsive to treatment. Eight patients were on no treatment, with 5 cases remained stable, 2 patients improved spontaneously, and 1 patient was lost follow-up. Intrathoracic lesions are not rare in patients with IgG4-RD, involving bronchial thickening, nodules, ground glass opacity, pleural thickening/effusion, lymphadenopathy, etc. Efficacy of corticosteroid and immunosuppressant therapy were noted in most of patients with lung interstitial disease, mediastinal mass, and bronchial thickening.
机译:目的探讨胸腔内受累的IgG4相关疾病(IgG4-RD)患者的临床和放射学特征。从2011年1月至2015年3月,在北京协和医院进行了一项前瞻性队列研究,并纳入了IgG4-RD患者,总结了胸腔内受累的IgG4-RD患者的临床和放射学特征。在248例IgG4-RD患者中,有87例胸腔内病变,其中男性58例,女性29例,平均年龄为54.19±13.80岁。肝门和纵隔淋巴结肿大是IgG4相关胸腔内疾病的最常见表现,占52.9%(46/87)。肺部疾病的其他影像学表现包括:实性结节(25.3%),圆形磨玻璃样混浊(9.2%),肺泡间质型(20.7%),支气管血管型(23.0%),胸腔积液(4.6%),和胸膜结节或增厚(16.1%)。仅27例患者出现呼吸道症状,包括咳嗽,呼吸困难,胸痛和哮喘。与没有胸腔内疾病的患者相比,与IgG4相关的胸腔内疾病具有更高的IgG4和C反应蛋白水平,并且过敏,发烧和多器官受累的发生率更高。多数肺间质疾病,纵隔肿块和支气管增厚对皮质类固醇和免疫抑制剂治疗敏感,而孤立结节性病变的36.3%(8/22)对治疗无反应。 8例未接受治疗,5例保持稳定,2例自发改善,1例失去随访。 IgG4-RD患者的胸腔内病变并不罕见,包括支气管增厚,结节,玻璃液混浊,胸膜增厚/积液,淋巴结病等。大多数患有肺间质疾病,纵隔肿块的患者都注意到皮质类固醇的疗效和免疫抑制剂治疗和支气管增厚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号